FMR LLC - NOVARTIS A G ownership

NOVARTIS A G's ticker is NVS and the CUSIP is 66987V109. A total of 1,197 filers reported holding NOVARTIS A G in Q3 2023. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
FMR LLC ownership history of NOVARTIS A G
ValueSharesWeighting
Q3 2023$124,431,075
+4.0%
1,221,589
+3.1%
0.01%
+10.0%
Q2 2023$119,610,690
-41.4%
1,185,320
-46.6%
0.01%
+11.1%
Q1 2023$204,094,168
+75.4%
2,218,414
+72.9%
0.01%
-25.0%
Q4 2022$116,371,776
+6.6%
1,282,757
-10.7%
0.01%
+9.1%
Q3 2022$109,132,000
-8.6%
1,435,751
+1.6%
0.01%
-8.3%
Q2 2022$119,417,000
+1.4%
1,412,717
+5.2%
0.01%
+33.3%
Q1 2022$117,812,000
+14.1%
1,342,581
+13.8%
0.01%
+12.5%
Q4 2021$103,229,000
+13.9%
1,180,173
+6.5%
0.01%
+14.3%
Q3 2021$90,647,000
-21.5%
1,108,420
-12.5%
0.01%
-22.2%
Q2 2021$115,528,000
+16.1%
1,266,203
+8.8%
0.01%
+12.5%
Q1 2021$99,504,000
-19.9%
1,164,072
-11.6%
0.01%
-27.3%
Q4 2020$124,280,000
+19.5%
1,316,122
+10.0%
0.01%0.0%
Q3 2020$103,999,000
+20.1%
1,195,941
+20.6%
0.01%
+10.0%
Q2 2020$86,620,000
-22.3%
991,761
-26.7%
0.01%
-33.3%
Q1 2020$111,498,000
-80.4%
1,352,300
-77.5%
0.02%
-76.2%
Q4 2019$569,360,000
-0.8%
6,012,889
-9.0%
0.06%
-8.7%
Q3 2019$573,921,000
-13.6%
6,604,389
-9.2%
0.07%
-11.5%
Q2 2019$664,330,000
-20.4%
7,275,541
-16.2%
0.08%
-22.0%
Q1 2019$834,356,000
+38.6%
8,678,552
+23.7%
0.10%
+22.0%
Q4 2018$602,046,000
+439.4%
7,016,047
+441.6%
0.08%
+530.8%
Q3 2018$111,611,000
+25.3%
1,295,397
+9.9%
0.01%
+30.0%
Q2 2018$89,057,000
-20.8%
1,178,943
-15.2%
0.01%
-23.1%
Q1 2018$112,421,000
-3.6%
1,390,481
+0.1%
0.01%
-7.1%
Q4 2017$116,629,000
-45.4%
1,389,108
-44.2%
0.01%
-46.2%
Q3 2017$213,546,000
+11.5%
2,487,424
+8.4%
0.03%
+8.3%
Q2 2017$191,546,000
+205.8%
2,294,782
+172.1%
0.02%
+200.0%
Q1 2017$62,636,000
+2.4%
843,341
+0.4%
0.01%0.0%
Q4 2016$61,173,000
-23.2%
839,817
-16.7%
0.01%
-27.3%
Q3 2016$79,610,000
-20.2%
1,008,229
-16.6%
0.01%
-21.4%
Q2 2016$99,704,000
+88.6%
1,208,384
+65.6%
0.01%
+100.0%
Q1 2016$52,860,000
-40.8%
729,705
-29.6%
0.01%
-41.7%
Q4 2015$89,233,000
-31.2%
1,037,115
-26.5%
0.01%
-33.3%
Q3 2015$129,670,000
-75.7%
1,410,688
-74.0%
0.02%
-73.5%
Q2 2015$532,747,000
+21.6%
5,417,398
+21.9%
0.07%
+21.4%
Q1 2015$438,177,000
+75.7%
4,443,532
+65.1%
0.06%
+75.0%
Q4 2014$249,411,000
+4.9%
2,691,681
+6.6%
0.03%0.0%
Q3 2014$237,769,000
-6.9%
2,525,964
-10.4%
0.03%
-5.9%
Q2 2014$255,357,000
+1.0%
2,820,687
-5.1%
0.03%
-2.9%
Q1 2014$252,755,000
+23.2%
2,972,876
+16.4%
0.04%
+20.7%
Q4 2013$205,209,000
+46.6%
2,552,992
+39.9%
0.03%
+38.1%
Q3 2013$139,981,000
+10.9%
1,824,820
+2.2%
0.02%0.0%
Q2 2013$126,215,0001,784,9620.02%
Other shareholders
NOVARTIS A G shareholders Q3 2023
NameSharesValueWeighting ↓
NEXTHERA CAPITAL LP 198,000$14,422,0008.45%
PRENTISS SMITH & CO INC 133,202$9,702,0005.92%
EXENCIAL WEALTH ADVISORS, LLC 178,313$12,988,0005.50%
MANAGED ASSET PORTFOLIOS, LLC 185,868$13,538,0005.33%
Osher Van de Voorde Investment Management 114,735$8,357,0004.59%
BROWN BROTHERS HARRIMAN & CO 10,971,272$799,147,0004.37%
PROFESSIONAL ADVISORY SERVICES INC 238,542$17,375,0004.04%
Elefante Mark B 4,579$333,0004.02%
COMPASS CAPITAL MANAGEMENT, INC 271,536$19,779,0003.69%
CGOV Asset Management 972,731$95,135,0003.51%
View complete list of NOVARTIS A G shareholders